Subscribe to RSS
DOI: 10.1055/s-0030-1271209
Maternal Characteristics of a Cohort of Preterm Infants with a Birth Weight ≤750 g without Major Structural Anomalies and Chromosomal Abnormalities
Publication History
Publication Date:
11 January 2011 (online)
![](https://www.thieme-connect.de/media/ajp/201105/lookinside/thumbnails/10.1055-s-0030-1271209-1.jpg)
ABSTRACT
Our objectives were to describe the obstetric complications of women who delivered an extremely low-birth-weight infant by comparing two consecutive 5-year periods and infants appropriate for gestational age (AGA) versus infants small for gestational age (SGA). This descriptive study included women (n = 261) who delivered an infant ≤750 g (major structural and chromosomal anomalies excluded) between 1996 and 2000 (cohort I, n = 145) and 2001 to 2005 (cohort II, n = 116) in the University Hospital Utrecht, the Netherlands. Of these, 84.3% of the multigravidas (n = 121) had a complicated obstetric history: 46.3% miscarriage(s), 22.3% preterm deliveries, and 16.5% hypertensive disorders. In the index pregnancies (n = 261), the most prevalent complications were hypertensive disorders (52.1%, p = 0.002; more in cohort II) and SGA (p = 0.007), fetal distress (39.5%), and intrauterine growth restriction (32.6%) resulting in a caesarean section in 47.9% and a spontaneous vaginal delivery in 19.2%. Intrauterine deaths occurred in 35.2%, merely due to placental insufficiency (59.8%) and termination of pregnancy because of deteriorating hypertensive disorders (23.9%). A high percentage of parous mothers had a seriously complicated obstetric history. The index pregnancy was largely complicated by hypertensive disorders. The majority of infants with a birth weight ≤750 g were growth-restricted due to placental insufficiency. Follow-up is extremely important to evaluate neonatal morbidity and neurodevelopmental outcome.
KEYWORDS
Extremely low-birth-weight infant - mother - obstetric complications - growth restriction
REFERENCES
- 1 Wilson-Costello D, Friedman H, Minich N, Fanaroff A A, Hack M. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s. Pediatrics. 2005; 115 997-1003
- 2 Stoelhorst G M, Rijken M, Martens S E Leiden Follow-Up Project on Prematurity et al. Changes in neonatology: comparison of two cohorts of very preterm infants (gestational age <32 weeks): the Project on Preterm and Small for Gestational Age Infants 1983 and the Leiden Follow-Up Project on Prematurity 1996-1997. Pediatrics. 2005; 115 396-405
- 3 Meadow W, Lee G, Lin K, Lantos J. Changes in mortality for extremely low birth weight infants in the 1990s: implications for treatment decisions and resource use. Pediatrics. 2004; 113 1223-1229
- 4 Shankaran S, Johnson Y, Langer J C et al.. Outcome of extremely-low-birth-weight infants at highest risk: gestational age < or =24 weeks, birth weight < or =750 g, and 1-minute Apgar < or =3. Am J Obstet Gynecol. 2004; 191 1084-1091
- 5 Hack M, Fanaroff A A. Outcomes of children of extremely low birthweight and gestational age in the 1990's. Early Hum Dev. 1999; 53 193-218
- 6 Roberts C L, Algert C S, Morris J M, Ford J B, Henderson-Smart D J. Hypertensive disorders in pregnancy: a population-based study. Med J Aust. 2005; 182 332-335
- 7 Brown M A, Mackenzie C, Dunsmuir W et al.. Can we predict recurrence of pre-eclampsia or gestational hypertension?. BJOG. 2007; 114 984-993
- 8 Sibai B M, Spinnato J A, Watson D L, Hill G A, Anderson G D. Pregnancy outcome in 303 cases with severe preeclampsia. Obstet Gynecol. 1984; 64 319-325
- 9 Hargood J L, Brown M A. Pregnancy-induced hypertension: recurrence rate in second pregnancies. Med J Aust. 1991; 154 376-377
- 10 Dukler D, Porath A, Bashiri A, Erez O, Mazor M. Remote prognosis of primiparous women with preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2001; 96 69-74
- 11 Iams J D, Goldenberg R L, Mercer B M National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network et al. The Preterm Prediction Study: recurrence risk of spontaneous preterm birth. Am J Obstet Gynecol. 1998; 178 1035-1040
- 12 Slattery M M, Geary M, Morrison J J. Obstetric antecedents for preterm delivery. J Perinat Med. 2008; 36 306-309
- 13 Dutch National Obstetric Registration 2002 Prismant. 2002
- 14 Martin J A, Hamilton B E, Ventura S J, Menacker F, Park M M, Sutton P D. Births: final data for 2001. Natl Vital Stat Rep. 2002; 51 1-102
- 15 Brown M A, Lindheimer M D, de Swiet M, Van Assche A, Moutquin J M. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001; 20 IX-XIV
- 16 Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982; 142 159-167
- 17 Hurd W W, Miodovnik M, Hertzberg V, Lavin J P. Selective management of abruptio placentae: a prospective study. Obstet Gynecol. 1983; 61 467-473
- 18 Leerentveld R A, Gilberts E CAM, Arnold M JCWJ, Wladimiroff J W. Accuracy and safety of transvaginal sonographic placental localization. Obstet Gynecol. 1990; 76 (5 Pt 1) 759-762
- 19 Blumenthal S A, Abdul-Karim R W. Diagnosis, classification, and metabolic management of diabetes in pregnancy: therapeutic impact of self-monitoring of blood glucose and of newer methods of insulin delivery. Obstet Gynecol Surv. 1987; 42 593-604
- 20 FIGO guidelines for the use of fetal monitoring. Int J Gynaecol Obstet. 1987; 25 159-167
- 21 Greer I A. Thrombosis in pregnancy: maternal and fetal issues. Lancet. 1999; 353 1258-1265
- 22 Quintero R A, Morales W J, Allen M H, Bornick P W, Johnson P K, Kruger M. Staging of twin-twin transfusion syndrome. J Perinatol. 1999; 19 (8 Pt 1) 550-555
-
23 The Netherlands Perinatal Registry. Birth weight centiles and SD. 2001. Available at: http://www.perinatreg.nl
- 24 Claas M J, Bruinse H W, van der Heide-Jalving M, Termote J UM, de Vries L S. Changes in survival and neonatal morbidity in infants with a birth weight of 750 g or less. Neonatology. 2010; 98 278-288
- 25 Morse S B, Wu S S, Ma C, Ariet M, Resnick M, Roth J. Racial and gender differences in the viability of extremely low birth weight infants: a population-based study. Pediatrics. 2006; 117 e106-e112
- 26 Vohr B R, Tyson J E, Wright L L, Perritt R L, Li L, Poole W K. Maternal Age, Multiple Birth, and Extremely Low Birth Weight Infants for the NICHD Neonatal Research Network. J Pediatr. 2009; 154 498-503
- 27 Duley L, Henderson-Smart D J, Knight M, King J F. Antiplatelet agents for preventing and treating pre-eclampsia. Cochrane Database Syst Rev. 2004; 1 CD004659
- 28 Rumbold A, Duley L, Crowther C A, Haslam R R. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev. 2008; (1) CD004227
- 29 Matchaba P T, Moodley J. WITHDRAWN: Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Syst Rev. 2009; (3) CD002076
- 30 Spencer K, Yu C K, Savvidou M, Papageorghiou A T, Nicolaides K H. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation. Ultrasound Obstet Gynecol. 2006; 27 658-663
- 31 Dodd J M, Flenady V, Cincotta R, Crowther C A. Prenatal administration of progesterone for preventing preterm birth. Cochrane Database Syst Rev. 2006; (1) CD004947
- 32 Chiolero A, Bovet P, Paccaud F. Association between maternal smoking and low birth weight in Switzerland: the EDEN study. Swiss Med Wkly. 2005; 135 (35-36) 525-530
- 33 Gazzaniga C A. Prevention of intrauterine growth retardation. J Okla State Med Assoc. 2002; 95 381-383
- 34 Claas M J, Bruinse H W, Koopman C, van Haastert I C, Peelen L M, de Vries L S. Two-year neurodevelopmental outcome of preterm born children ≤750 gram at birth. Arch Dis Child Fetal Neonatal Ed. 2010 Jun 7; (Epub ahead of print)
Marieke J ClaasM.D. Ph.D.
Department of Obstetrics and Gynaecology, University Medical Centre, Wilhelmina Children's Hospital
KE 04.123.1, P.O. Box 85090, 3508 AB, Utrecht, The Netherlands
Email: m.j.claas@umcutrecht.nl